Gilead Sciences, Inc. (GILD) is one of the best companies to hold during the pandemic
Gilead Sciences, Inc. (GILD) currently trades at $76.19 and has grown by 1.21% today. GILD went up $0.91 from the previous closing price of $75.28. The high forecast for Gilead Sciences, Inc. is $90.00 and the low is $58.00. The company’s market cap is $95.92 billion with a 52 week high of $85.97 and a 52 week low of $60.89. GILD has changed in price by 10.73 per share in the last 12 months.
Gilead Sciences, Inc. has a strong EPS of 4.22. This means the company made $4.22 per share after paying dividends, this can indicate that the stock is a safe investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 7 out of 10. We give it this rating based on current information written in this article.
About Gilead Sciences, Inc.:
Gilead is dedicated to developing innovative medicines for life-threatening illnesses. As we pursue this goal, we strive for positive social and environmental change within our company and our supply chain. Our Corporate Social Responsibility (CSR) program is built to focus on patients, society, the planet and our business practices.